Infectious Disease Drugs

1,157 FDA-approved drugs

TheraRadar tracks 1,157 FDA-approved infectious disease drugs from 336 companies across 61 drug classes, led by Pfizer, with 1,228 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Infectious Disease.

Upcoming Infectious Disease Phase 3 readouts →

Infectious Disease Approvals by Year

21

'15

16

'16

16

'17

33

'18

11

'19

14

'20

14

'21

10

'22

9

'23

12

'24

11

'25

5

'26

Recent Infectious Disease Drug Approvals

IDVYNSO™ is indicated as a complete two-drug regimen for the treatment of human immunodeficiency vir...

NORWICH PHARMACEUTICALS INC

EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE

RILPIVIRINE HYDROCHLORIDE

RILPIVIRINE HYDROCHLORIDE

human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral treatment-naïve patients 12 ...

SOMERSET THERAPS LLC

SOMERSET THERAPS LLC

uncomplicated urogenital gonorrhea due to Neisseria gonorrhoeae in adults and pediatric patients 12 ...

CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE

CIPROFLOXACIN HYDROCHLORIDE

acute otitis externa in adult and pediatric patients, one year and older, due to susceptible strains...

COSETTE PHARMS NC

DALBAVANCIN HYDROCHLORIDE

DALBAVANCIN HYDROCHLORIDE

adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused...

FOSFOMYCIN DISODIUM

patients 18 years of age and older with complicated urinary tract infections (cUTI) including acute ...

fungal otitis externa (otomycosis) due to Aspergillus species and Candida species in patients 18 yea...

CARWIN PHARM ASSOC

pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in adults and adolesce...

Gilead Sciences

CLESROVIMAB-CFOR

the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in neonates and ...

EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE

use as a complete regimen for the treatment of HIV-1 infection in patients weighing at least 35 kg (...

LAURUS LABS LTD

PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER

PIPERACILLIN SODIUM

the treatment of: Intra-abdominal infections in adult and pediatric patients 2 months of age and old...

B BRAUN MEDICAL

GEPOTIDACIN MESYLATE

the following infections caused by susceptible microorganisms: • Uncomplicated urinary tract infecti...

AVIBACTAM SODIUM

EMBLAVEO is a combination of aztreonam, a monobactam antibacterial, and avibactam, a beta-lactamase ...

RALTEGRAVIR POTASSIUM

RALTEGRAVIR POTASSIUM

HETERO LABS LTD III

uncomplicated urinary tract infections (uUTI) caused by the designated microorganisms Escherichia co...

EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

Showing the 20 most recent of 1,157 infectious disease drugs. View all 1,157 →

Top Infectious Disease Companies

Pfizer 77 GSK 33 Merck 30 Bristol-Myers Squibb 30 APOTHECON 30 Teva 26 Bayer 26 Roche 24 Eli Lilly 24 Gilead Sciences 22

Infectious Disease Active Trials by Indication

1,228 active trials — the forward pipeline, not just approvals.

HIV 321 COVID-19 164 Hepatitis B 134 Sepsis 116 Tuberculosis 105 Influenza 98 Malaria 71 RSV 70

All competitive landscapes →

Infectious Disease Drug Classes

Azole Antifungal 17

Nitroimidazole Antimicrobial 12

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor 10

Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor 9

Cytochrome P450 3A Inhibitor 7

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor 6

Corticosteroid 5

Nitrofuran Antibacterial 5

Rifamycin Antimycobacterial 4

Polyene Antifungal 4

Infectious Disease at a Glance

Total Drugs: 1157
Companies: 336
Drug Classes: 61
Active Trials: 1,228
Latest Approval: 2026-04-20